A Phase I Clinical Study of KSD-101 in Patients With Relapsed or Refractory EBV-associated Hematological Malignancies
Kousai Bio Co., Ltd.
Kousai Bio Co., Ltd.
University of Pennsylvania
University of Arizona
Institute of Hematology & Blood Diseases Hospital, China
M.D. Anderson Cancer Center
Baylor College of Medicine
Institute of Hematology & Blood Diseases Hospital, China
Cancer Research UK
Wake Forest University Health Sciences
Beth Israel Deaconess Medical Center
The 923rd Hospital of Joint Logistics Support Force of People's Liberation Army
Sichuan University
Massachusetts General Hospital
M.D. Anderson Cancer Center
Affiliated Hospital of Jiangsu University
Baylor College of Medicine
University of Salamanca
Hospital del Salvador
Instituto de Investigación Biomédica de Salamanca
University Hospital, Strasbourg, France
Necmettin Erbakan University
Assistance Publique Hopitaux De Marseille
Ankara University
Halic University
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
Assiut University
Centre Hospitalier Universitaire de Nice
Shanghai Jiao Tong University School of Medicine
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Peking University First Hospital
Augusta University
The First Affiliated Hospital with Nanjing Medical University
Ciusss de L'Est de l'Île de Montréal
The University of Hong Kong
Institute of Hematology & Blood Diseases Hospital, China
Massachusetts General Hospital
National Taiwan University Hospital
University Hospital, Grenoble
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Zhejiang Provincial People's Hospital
University of Modena and Reggio Emilia
Great Ormond Street Hospital for Children NHS Foundation Trust
Assiut University
Brigham and Women's Hospital
Beijing 302 Hospital
Assistance Publique - Hôpitaux de Paris
University Hospital, Caen
Institut Paoli-Calmettes
University College, London
Institut Paoli-Calmettes